-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Maintains Buy on Evolent Health, Raises Price Target to $6

Benzinga·08/17/2026 15:47:49
Listen to the news
TD Cowen analyst Charles Rhyee maintains Evolent Health (NYSE:EVH) with a Buy and raises the price target from $5 to $6.